Ken Griffin
DBTX

Ken Griffin’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Ken Griffin’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,787,311
Closed -$3.66M – 15884
2022
Q4 		$3.66M Sell
1,787,311
-21,675
-1% -$66K ﹤0.01% 4407
2022
Q3 		$6.26M Buy
1,808,986
+16,678
+0.9% +$75.9K ﹤0.01% 3514
2022
Q2 		$7.55M Buy
1,792,308
+18,617
+1% +$44K ﹤0.01% 3070
2022
Q1 		$5.39M Buy
1,773,691
+130
+0% +$498 ﹤0.01% 4026
2021
Q4 		$8.25M Sell
1,773,561
-4,098
-0.2% -$28.2K ﹤0.01% 3385
2021
Q3 		$13.7M Buy
1,777,659
+3,828
+0.2% +$29.2K ﹤0.01% 2568
2021
Q2 		$14.9M Sell
1,773,831
-4,565
-0.3% -$40.3K ﹤0.01% 2479
2021
Q1 		$20.2M Buy
+1,778,396
New +$27.9M 0.01% 1949

Other funds holding DBTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ken Griffin's DBTX Position: Q1 2023 in Review

Ken Griffin sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q1 2023, closing a stake of 1,787,311 shares — an estimated $3.66M sold.

Ken Griffin first reported a position in DBTX in Q1 2021 and held it in 8 quarters. The position peaked at $20.2M in Q1 2021. 38 funds tracked by Wall St. Rank hold DBTX as of Q1 2023.

  • Ken Griffin reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Ken Griffin sold 1,787,311 Decibel Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $3.66M.
  • Ken Griffin first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • Ken Griffin's Decibel Therapeutics, Inc. Common Stock position peaked at $20.2M in Q1 2021.
  • 38 funds tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.